Compare Baqsimi With IM Glucagon for Severe Hypoglycemia

January 2020

Baqsimi (bak-SEE-mee) is a new INTRANASAL glucagon that will be a game changer for treating severe hypoglycemia.

Quick response is key. Severe hypoglycemia causes confusion, seizures, and loss of consciousness...increasing risk of injury and death.

Baqsimi is a ready-to-use powder sprayed in one nostril for patients 4 years and older...and is absorbed without inhaling.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

Supplements Help Patients Avoid Mishaps With Cold and Flu Supplements
Hypertension Don't Rely on the Timing of BP Meds to Improve CV Outcomes
Hypoglycemia Compare Baqsimi With IM Glucagon for Severe Hypoglycemia
COPD Expect Eosinophils to Guide Whether to Start Inhaled Steroids for COPD
Stroke Recommend Target Statin Doses and Consider LDL After a Stroke
Autism Help Optimize Meds for Kids With Autism Spectrum Disorder
Cultural Awareness Optimize Communication With Transgender and Gender-Diverse Patients
HIV & AIDS Be Alert for Patients Who Need HIV Post-Exposure Prophylaxis (nPEP)
Gastroenterology Help Answer Questions About EsopH for Acid Reflux
Dermatology Be Ready to Identify and Manage Hidradenitis Suppurativa